Granahan Investment Management LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 165 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Granahan Investment Management ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$1,019
-90.5%
9,063
-86.9%
0.02%
-88.6%
Q4 2021$10,680
-34.5%
69,141
-40.9%
0.22%
-28.8%
Q3 2021$16,305
-23.5%
117,033
-28.0%
0.31%
-22.2%
Q2 2021$21,327
-44.1%
162,565
-35.1%
0.40%
-51.0%
Q1 2021$38,179
+98.6%
250,436
+29.5%
0.81%
+87.5%
Q4 2020$19,228
+129.7%
193,339
+120.1%
0.43%
+52.1%
Q3 2020$8,371
+59.7%
87,823
+87.3%
0.28%
+49.5%
Q2 2020$5,243
+42.7%
46,878
-7.2%
0.19%
-4.0%
Q1 2020$3,673
+195.5%
50,514
+323.7%
0.20%
+247.4%
Q4 2019$1,243
-39.2%
11,921
-42.0%
0.06%
-49.6%
Q3 2019$2,046
+2.2%
20,556
+17.2%
0.11%
+14.1%
Q2 2019$2,002
-53.3%
17,541
-48.5%
0.10%
-57.0%
Q1 2019$4,283
-56.2%
34,074
-52.8%
0.23%
-66.8%
Q4 2018$9,787
+37.7%
72,125
+178.6%
0.69%
+79.5%
Q3 2018$7,106
+91.7%
25,889
+44.7%
0.39%
+73.1%
Q2 2018$3,707
-33.1%
17,895
-46.6%
0.22%
-44.2%
Q1 2018$5,538
+4.0%
33,533
-13.8%
0.40%
-4.5%
Q4 2017$5,325
+10.9%
38,889
+10.3%
0.42%
+4.5%
Q3 2017$4,802
+21.1%
35,272
+8.0%
0.40%
+9.6%
Q2 2017$3,966
+25.1%
32,670
+9.1%
0.37%
+15.1%
Q1 2017$3,170
-90.4%
29,951
-90.8%
0.32%
-72.0%
Q4 2016$33,023
+5.9%
325,000
+6.4%
1.14%
+11.2%
Q3 2016$31,172
-19.5%
305,424
-6.0%
1.02%
-27.7%
Q2 2016$38,742
-5.4%
324,824
-15.1%
1.41%
-5.2%
Q1 2016$40,975
+5.4%
382,624
+6.7%
1.49%
+11.4%
Q4 2015$38,882
+16.1%
358,624
-8.3%
1.34%
+28.9%
Q3 2015$33,489
-5.1%
391,000
+11.8%
1.04%
+3.8%
Q2 2015$35,275
+233.2%
349,600
+154.6%
1.00%
+229.7%
Q1 2015$10,587137,3000.30%